Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Epirubicin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

pembrolizumab 98 Carboplatin 53 Cisplatin 47 Nivolumab 46 Specimen Handling 42 Paclitaxel 42 Cyclophosphamide 42 Biopsy 42 Magnetic Resonance Spectroscopy 38 Radiotherapy 32 Ipilimumab 29 Gemcitabine 29 Doxorubicin 27 durvalumab 26 Lenalidomide 26 Prednisone 24 Docetaxel 24 Dexamethasone 24 olaparib 22 fludarabine 22 Pemetrexed 21 Rituximab 20 Radiation 20 atezolizumab 19 Trastuzumab 18 Radiotherapy, Intensity-Modulated 18 Fulvestrant 18 enzalutamide 17 Vincristine 16 Taxes 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04770272 2026-01-12

neoMono

Palleos Healthcare GmbH

Phase 2 Terminated

442 enrolled 42 charts

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡